Healthcare Services

Global Peripheral Arterial Disease Market Set for Strong Expansion Reaching $7.28 Billion by 2030 at 9.2% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Peripheral Arterial Disease Market Over The 2026–2030 Period?

The peripheral arterial disease market has experienced robust growth in recent years. It is projected to expand from $4.74 billion in 2025 to $5.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. The market’s historical growth can be attributed to the significant prevalence of peripheral arterial disease, limited public awareness of PAD symptoms, a reliance on conventional medications, insufficient access to vascular specialists, and disjointed care delivery systems.

The peripheral arterial disease market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $7.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This expected growth over the projected timeframe stems from several factors, including developments in minimally invasive endovascular techniques, the increasing acceptance of drug-eluting devices, the proliferation of hospitals and specialized clinics dedicated to PAD care, greater patient understanding of the benefits of early intervention, and a rising reliance on comprehensive treatment plans involving both lifestyle adjustments and medications. Key trends predicted for this period encompass the expanded application of AI in prompt diagnosis and risk evaluation, the greater uptake of digital and cloud-powered patient monitoring solutions, an intensifying focus on individualized PAD treatments informed by genomics, the broader deployment of IoT-enabled gadgets for tracking outcomes after treatment, and the increasing incorporation of smart manufacturing methods in the production of PAD devices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

What Drivers Are Expected To Influence The Peripheral Arterial Disease Market During The Forecast Period?

The increasing incidence of diabetes is projected to fuel the expansion of the peripheral arterial disease market in the future. Diabetes is defined as a long-term metabolic condition marked by elevated blood glucose levels. Consequently, as diabetes becomes more widespread, the need for therapies addressing this condition also rises. The rising occurrence of diabetes significantly contributes to peripheral arterial disease (PAD), as individuals with diabetes face an elevated risk of developing atherosclerosis, which stands as the primary cause of PAD and necessitates medical intervention. For example, in March 2024, data from reports released by The Office for Health Improvement and Disparities (OHID), a UK-based government agency, indicated that during the 15 months concluding in March 2023, compared to the period ending in March 2022, the proportion of individuals with type 1 diabetes undergoing eight care processes increased by 22%, and for type 2 diabetes, this rise was 21%. Thus, the widespread increase in diabetes is a key driver for the growth of the peripheral arterial disease market.

How Is The Peripheral Arterial Disease Market Segmented Across Key Categories?

The peripheral arterial disease market covered in this report is segmented –

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Devices: Stents, Balloons, Atherectomy Devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

What Key Trends Are Influencing The Development Of The Peripheral Arterial Disease Market?

Leading companies in the peripheral arterial disease market are focusing on creating advanced medical devices, such as the intravascular lithotripsy (IVL) catheter, to boost treatment efficacy, improve patient outcomes, and shorten recovery times for individuals affected by vascular conditions. The intravascular lithotripsy (IVL) catheter is a medical instrument utilized to treat calcified arterial blockages by delivering precise shockwaves to break down calcium, thus helping to restore blood flow and enhance vessel flexibility during procedures like angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, launched the Shockwave E8 peripheral IVL catheter. This medical device is designed to address peripheral arterial disease by applying targeted intravascular lithotripsy, which employs sonic waves to disintegrate calcium deposits in arterial walls. This novel approach assists in re-establishing blood flow while reducing trauma to adjacent tissues. The catheter’s sophisticated design enables easier navigation through complex vascular anatomy, rendering it suitable for a wide range of patients.

Who Are The Dominant Players Shaping The Peripheral Arterial Disease Market Landscape?

Major companies operating in the peripheral arterial disease market are Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC

Read the full peripheral arterial disease market report here:

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Which Region Is Forecast To Lead The Peripheral Arterial Disease Market In Terms Of Market Size?

North America was the largest region in the peripheral artery disease market in 2025. The regions covered in the peripheral arterial disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peripheral Arterial Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp

Browse Through More Reports Similar to the Global Peripheral Arterial Disease Market 2026, By The Business Research Company

Oral Hygiene Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-hygiene-global-market-report

Oral Care Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Endodontics Global Market Report

https://www.thebusinessresearchcompany.com/report/endodontics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795